(HealthDay)—Although most Medicare Part D plans cover at least one biologic disease-modifying antirheumatic drug (DMARD), copayments are high, according to a study published in the June issue of Arthritis & Rheumatology.
Jun 4, 2015
0
4
Montana State University researchers and their collaborators have published their findings about a chemical compound that shows potential for treating rheumatoid arthritis.
May 21, 2015
0
11
(HealthDay)—Genetic variations may hold clues to rheumatoid arthritis—suggesting not only who will develop the painful condition, but also predicting its severity and even who might die from it, a new study says.
Apr 28, 2015
0
117
The first national investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief ...
Apr 21, 2015
0
21
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just ...
Apr 16, 2015
0
4
Clad in white lab coats, blue gloves and safety goggles, scientists are buzzing around a lab at Hospira in this suburb north of Chicago.
Mar 31, 2015
0
8
Mati Munoz lost her liver to hepatitis C, and the virus was attacking its transplanted replacement last year when her doctor prescribed a drug combination that could save the organ.
Mar 11, 2015
0
4
Smoking impairs the response to biological drugs used to treat inflammatory arthritis affecting the lower back, known as axial spondyloarthritis, or AxSpA, for short, reveals research published online in the Annals of the ...
Feb 9, 2015
0
11
(HealthDay)—Pain-relieving treatments for knee arthritis all work better than doing nothing—but it's hard to point to a clear winner, a new research review concluded.
Jan 6, 2015
0
7
Swiss pharmaceutical company Novartis said Friday it has won approval to market its Cosentyx psoriasis treatment in Japan, making it the first country to authorise commercialisation of the drug.
Dec 26, 2014
0
0
